Artelo Biosciences Retained Earnings (Accumulated Deficit) 2016-2024 | ARTL
Artelo Biosciences retained earnings (accumulated deficit) from 2016 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.